Adynxx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Adynxx and buy or sell other stocks, ETFs, and their options commission-free!About ADYX
Adynxx, Inc. is a clinical stage biopharmaceutical company, which engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in 2007 and is headquartered in San Francisco, CA.
CEORick Orr
CEORick Orr
Employees6
Employees6
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2007
Founded2007
Employees6
Employees6
ADYX Key Statistics
Market cap580.80
Market cap580.80
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume70.60
Average volume70.60
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0002
52 Week high$0.0002
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
Adynxx(ADYX) stock is priced at $0.00, giving the company a market capitalization of 580.8.
On 2026-03-06, Adynxx(ADYX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 70.6.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.
The stock's 52-week range extends from a low of $0.00 to a high of $0.00.